• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于公共卫生问题和对 COVID-19 疫苗犹豫的深度学习预测模型。

A deep learning predictive model for public health concerns and hesitancy toward the COVID-19 vaccines.

机构信息

Computer Science Department, Faculty of Science, Minia University, Minya, Egypt.

Scientific Research Group in Egypt (SRGE).

出版信息

Sci Rep. 2023 Jun 6;13(1):9171. doi: 10.1038/s41598-023-36319-6.

DOI:10.1038/s41598-023-36319-6
PMID:37280253
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10242606/
Abstract

Throughout the pandemic era, COVID-19 was one of the remarkable unexpected situations over the past few years, but with the decentralization and globalization of efforts and knowledge, a successful vaccine-based control strategy was efficiently designed and applied worldwide. On the other hand, excused confusion and hesitation have widely impacted public health. This paper aims to reduce COVID-19 vaccine hesitancy taking into consideration the patient's medical history. The dataset used in this study is the Vaccine Adverse Event Reporting System (VAERS) dataset which was created as a corporation between the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) to gather reported side effects that may be caused by PFIEZER, JANSSEN, and MODERNA vaccines. In this paper, a Deep Learning (DL) model has been developed to identify the relationship between a certain type of COVID-19 vaccine (i.e. PFIEZER, JANSSEN, and MODERNA) and the adverse reactions that may occur in vaccinated patients. The adverse reactions under study are the recovery condition, possibility to be hospitalized, and death status. In the first phase of the proposed model, the dataset has been pre-proceesed, while in the second phase, the Pigeon swarm optimization algorithm is used to optimally select the most promising features that affect the performance of the proposed model. The patient's status after vaccination dataset is grouped into three target classes (Death, Hospitalized, and Recovered). In the third phase, Recurrent Neural Network (RNN) is implemented for both each vaccine type and each target class. The results show that the proposed model gives the highest accuracy scores which are 96.031% for the Death target class in the case of PFIEZER vaccination. While in JANSSEN vaccination, the Hospitalized target class has shown the highest performance with an accuracy of 94.7%. Finally, the model has the best performance for the Recovered target class in MODERNA vaccination with an accuracy of 97.794%. Based on the accuracy and the Wilcoxon Signed Rank test, we can conclude that the proposed model is promising for identifying the relationship between the side effects of COVID-19 vaccines and the patient's status after vaccination. The study displayed that certain side effects were increased in patients according to the type of COVID-19 vaccines. Side effects related to CNS and hemopoietic systems demonstrated high values in all studied COVID-19 vaccines. In the frame of precision medicine, these findings can support the medical staff to select the best COVID-19 vaccine based on the medical history of the patient.

摘要

在整个大流行时代,COVID-19 是过去几年中一个显著的意外情况,但随着努力和知识的去中心化和全球化,一种成功的基于疫苗的控制策略已在全球范围内得到有效设计和应用。另一方面,由于公众的困惑和犹豫,对公共卫生产生了广泛影响。本文旨在考虑患者的病史,减少 COVID-19 疫苗犹豫。本研究使用的数据集是疫苗不良事件报告系统(VAERS)数据集,该数据集由美国食品和药物管理局(FDA)和疾病控制与预防中心(CDC)创建,用于收集可能由辉瑞、杨森和莫德纳疫苗引起的报告副作用。在本文中,开发了一种深度学习(DL)模型来识别特定类型的 COVID-19 疫苗(即辉瑞、杨森和莫德纳)与接种疫苗患者可能发生的不良反应之间的关系。研究中的不良反应是康复情况、住院可能性和死亡状态。在提出的模型的第一阶段,对数据集进行了预处理,而在第二阶段,使用鸽子群优化算法来优化选择影响提出的模型性能的最有前途的特征。接种疫苗后患者的状态数据集分为三个目标类别(死亡、住院和康复)。在第三阶段,为每个疫苗类型和每个目标类别实施了循环神经网络(RNN)。结果表明,所提出的模型在辉瑞疫苗接种的死亡目标类中给出了最高的准确率,为 96.031%。而在杨森疫苗接种中,住院目标类的表现最佳,准确率为 94.7%。最后,在莫德纳疫苗接种中,该模型在康复目标类中表现最佳,准确率为 97.794%。基于准确性和 Wilcoxon 符号秩检验,我们可以得出结论,所提出的模型在识别 COVID-19 疫苗的副作用与接种疫苗后患者的状态之间的关系方面具有很大的前景。研究显示,根据 COVID-19 疫苗的类型,某些副作用在患者中增加。与中枢神经系统和造血系统相关的副作用在所有研究的 COVID-19 疫苗中均显示出较高的值。在精准医学的框架内,这些发现可以支持医务人员根据患者的病史选择最佳的 COVID-19 疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/663d972c6ecf/41598_2023_36319_Fig23_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/195158ca20c2/41598_2023_36319_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/1b916b74a1ad/41598_2023_36319_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/5c31d1d2c395/41598_2023_36319_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/aded2744aee2/41598_2023_36319_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/70aea5d1806d/41598_2023_36319_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/4aa12ebb994a/41598_2023_36319_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/91889d4eb6ce/41598_2023_36319_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/c9e2d73d01b3/41598_2023_36319_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/644923fc3472/41598_2023_36319_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/678388eb7c19/41598_2023_36319_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/d2ffe0e5d5ef/41598_2023_36319_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/49ea87575d21/41598_2023_36319_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/9860784ea4c5/41598_2023_36319_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/17a834eeec44/41598_2023_36319_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/10607e678081/41598_2023_36319_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/be2687e3749b/41598_2023_36319_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/d4c306bbd3a4/41598_2023_36319_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/a90adc7a56e2/41598_2023_36319_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/8a7b3c3f5431/41598_2023_36319_Fig19_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/d61ea50fc630/41598_2023_36319_Fig20_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/59bd138d2090/41598_2023_36319_Fig21_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/8383c19b0650/41598_2023_36319_Fig22_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/663d972c6ecf/41598_2023_36319_Fig23_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/195158ca20c2/41598_2023_36319_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/1b916b74a1ad/41598_2023_36319_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/5c31d1d2c395/41598_2023_36319_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/aded2744aee2/41598_2023_36319_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/70aea5d1806d/41598_2023_36319_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/4aa12ebb994a/41598_2023_36319_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/91889d4eb6ce/41598_2023_36319_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/c9e2d73d01b3/41598_2023_36319_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/644923fc3472/41598_2023_36319_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/678388eb7c19/41598_2023_36319_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/d2ffe0e5d5ef/41598_2023_36319_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/49ea87575d21/41598_2023_36319_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/9860784ea4c5/41598_2023_36319_Fig13_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/17a834eeec44/41598_2023_36319_Fig14_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/10607e678081/41598_2023_36319_Fig15_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/be2687e3749b/41598_2023_36319_Fig16_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/d4c306bbd3a4/41598_2023_36319_Fig17_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/a90adc7a56e2/41598_2023_36319_Fig18_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/8a7b3c3f5431/41598_2023_36319_Fig19_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/d61ea50fc630/41598_2023_36319_Fig20_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/59bd138d2090/41598_2023_36319_Fig21_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/8383c19b0650/41598_2023_36319_Fig22_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22f5/10244443/663d972c6ecf/41598_2023_36319_Fig23_HTML.jpg

相似文献

1
A deep learning predictive model for public health concerns and hesitancy toward the COVID-19 vaccines.用于公共卫生问题和对 COVID-19 疫苗犹豫的深度学习预测模型。
Sci Rep. 2023 Jun 6;13(1):9171. doi: 10.1038/s41598-023-36319-6.
2
Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.在报告 Janssen(强生)和 mRNA COVID-19 疫苗(辉瑞-生物科技和莫德纳)成年受种者发生不良事件后使用 COVID-19 疫苗:免疫实践咨询委员会的更新-美国,2021 年 7 月。
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1094-1099. doi: 10.15585/mmwr.mm7032e4.
3
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021.强生(Johnson & Johnson)COVID-19 疫苗安全性监测-美国,2021 年 3 月-4 月。
MMWR Morb Mortal Wkly Rep. 2021 May 7;70(18):680-684. doi: 10.15585/mmwr.mm7018e2.
4
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination - Five U.S. Mass Vaccination Sites, April 2021.辉瑞 COVID-19 疫苗接种后与焦虑相关的不良事件群 - 美国五个大规模疫苗接种点,2021 年 4 月。
MMWR Morb Mortal Wkly Rep. 2021 May 7;70(18):685-688. doi: 10.15585/mmwr.mm7018e3.
5
Safety Monitoring of an Additional Dose of COVID-19 Vaccine - United States, August 12-September 19, 2021.COVID-19 疫苗追加剂量的安全性监测 - 美国,2021 年 8 月 12 日至 9 月 19 日。
MMWR Morb Mortal Wkly Rep. 2021 Oct 1;70(39):1379-1384. doi: 10.15585/mmwr.mm7039e4.
6
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.2021年3月至8月美国Moderna、辉瑞-生物科技公司和杨森(强生)疫苗在预防无免疫功能低下状况成年人新冠病毒肺炎住院方面的比较效果
MMWR Morb Mortal Wkly Rep. 2021 Sep 24;70(38):1337-1343. doi: 10.15585/mmwr.mm7038e1.
7
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022.COVID-19 疫苗加强针接种后的安全性监测-美国,2021 年 9 月 22 日-2022 年 2 月 6 日。
MMWR Morb Mortal Wkly Rep. 2022 Feb 18;71(7):249-254. doi: 10.15585/mmwr.mm7107e1.
8
Assessment of Sudden Sensorineural Hearing Loss After COVID-19 Vaccination.评估 COVID-19 疫苗接种后的突发性感觉神经性听力损失。
JAMA Otolaryngol Head Neck Surg. 2022 Apr 1;148(4):307-315. doi: 10.1001/jamaoto.2021.4414.
9
Vaccine-Associated Uveitis after COVID-19 Vaccination: Vaccine Adverse Event Reporting System Database Analysis.接种新冠疫苗后出现的葡萄膜炎:疫苗不良事件报告系统数据库分析。
Ophthalmology. 2023 Feb;130(2):179-186. doi: 10.1016/j.ophtha.2022.08.027. Epub 2022 Aug 31.
10
Making US poison centers a part of the solution to the COVID-19 pandemic.使美国中毒控制中心成为 COVID-19 大流行解决方案的一部分。
Clin Toxicol (Phila). 2022 Jan;60(1):102-114. doi: 10.1080/15563650.2021.1933510. Epub 2021 Aug 27.

引用本文的文献

1
Exploring the anticancer activities of Sulfur and magnesium oxide through integration of deep learning and fuzzy rough set analyses based on the features of Vidarabine alkaloid.基于阿糖腺苷生物碱的特征,通过深度学习与模糊粗糙集分析相结合的方法探索硫和氧化镁的抗癌活性。
Sci Rep. 2025 Jan 17;15(1):2224. doi: 10.1038/s41598-024-82483-8.

本文引用的文献

1
Deep learning in drug discovery: an integrative review and future challenges.药物发现中的深度学习:综合综述与未来挑战
Artif Intell Rev. 2023;56(7):5975-6037. doi: 10.1007/s10462-022-10306-1. Epub 2022 Nov 17.
2
A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19.抗2019冠状病毒病蛋白质亚基疫苗综述
Front Microbiol. 2022 Jul 14;13:927306. doi: 10.3389/fmicb.2022.927306. eCollection 2022.
3
Using a Deep Learning Model to Explore the Impact of Clinical Data on COVID-19 Diagnosis Using Chest X-ray.
使用深度学习模型探索临床数据对 COVID-19 诊断的胸部 X 光片的影响。
Sensors (Basel). 2022 Jan 16;22(2):669. doi: 10.3390/s22020669.
4
Machine learning techniques to predict different levels of hospital care of CoVid-19.用于预测新冠肺炎不同级别医院护理的机器学习技术。
Appl Intell (Dordr). 2022;52(6):6413-6431. doi: 10.1007/s10489-021-02743-2. Epub 2021 Sep 10.
5
Deep learning for COVID-19 detection based on CT images.基于 CT 图像的 COVID-19 深度学习检测。
Sci Rep. 2021 Jul 12;11(1):14353. doi: 10.1038/s41598-021-93832-2.
6
Side Effects and Perceptions Following COVID-19 Vaccination in Jordan: A Randomized, Cross-Sectional Study Implementing Machine Learning for Predicting Severity of Side Effects.约旦新冠疫苗接种后的副作用及认知:一项采用机器学习预测副作用严重程度的随机横断面研究
Vaccines (Basel). 2021 May 26;9(6):556. doi: 10.3390/vaccines9060556.
7
The COVID-19 vaccine development: A pandemic paradigm.新型冠状病毒疫苗的研发:一种大流行范例。
Virus Res. 2021 Aug;301:198454. doi: 10.1016/j.virusres.2021.198454. Epub 2021 May 17.
8
Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases.印度的新冠疫苗接种策略:人口和病例数均位居第二的国家。
NPJ Vaccines. 2021 Apr 21;6(1):60. doi: 10.1038/s41541-021-00327-2.
9
Machine and Deep Learning towards COVID-19 Diagnosis and Treatment: Survey, Challenges, and Future Directions.面向COVID-19诊断与治疗的机器学习和深度学习:综述、挑战与未来方向
Int J Environ Res Public Health. 2021 Jan 27;18(3):1117. doi: 10.3390/ijerph18031117.
10
Artificial Intelligence Augmentation of Radiologist Performance in Distinguishing COVID-19 from Pneumonia of Other Origin at Chest CT.人工智能增强放射科医生在胸部 CT 上区分 COVID-19 与其他病因肺炎的性能。
Radiology. 2020 Sep;296(3):E156-E165. doi: 10.1148/radiol.2020201491. Epub 2020 Apr 27.